Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.23 HKD | +1.95% | 0.00% | -21.23% |
05-02 | Alphamab Oncology's 2023 Loss Narrows as Revenue Rises | MT |
04-10 | Alphamab Oncology Presents Phase-I Clinical Trial Results at 2024 AACR Annual Meeting | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.23% | 646M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- 9966 Stock
- News Alphamab Oncology
- Alphamab Oncology Unit Renews Service Provision Contract, Annual Limits